Home » Hologic Gets CE Mark for Its Aptima CMV Quant Assay
Hologic Gets CE Mark for Its Aptima CMV Quant Assay
Hologic has received the CE mark for its Aptima CMV (cytomegalovirus) Quant assay, a blood test for post-surgery monitoring of organ or stem-cell transplant patients.
The in vitro test, which runs on the Marlborough, Mass.-based company’s Panther system, measures the viral load of cytomegalovirus to protect transplant patients, as elevated viral loads are associated with a higher risk of developing CMV disease.
Hologic says the Aptima CMV Quant assay is the first in its new line of assays for transplant patients.
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May